SCHEMBL2614739

SCHEMBL2614739

COC(=O)c1ccc(OCC2CO2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.60
PKM P14618 2/20 0.55
RAB9A P51151 5/20 0.54
LMNA P02545 3/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
TP53 P04637 2/20 0.54
HPGD P15428 2/20 0.54
TSHR P16473 2/20 0.54
ALDH1A1 P00352 2/20 0.54
GAA P10253 2/20 0.54
CYP1A2 P05177 1/20 0.54
PPARG P37231 1/20 0.54
HIF1A Q16665 1/20 0.54
TDP1 Q9NUW8 2/20 0.53
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
NPC1 O15118 4/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
L3MBTL1 Q9Y468 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12579075 0.90 MAPT (0.55) MAPTPKMRAB9ALMNAMEN1
SCHEMBL28466842 0.88 MAPT (0.57) MAPTRAB9ALMNAHPGDTSHR
SCHEMBL9335265 0.86 MAPT (0.52) MAPTPKMRAB9ALMNAMEN1
SCHEMBL12924442 0.86 ALDH1A1 (0.55) MAPTPKMRAB9ALMNAMEN1
SCHEMBL9483425 0.86 ALDH1A1 (0.55) MAPTPKMRAB9ALMNAMEN1
SCHEMBL19892095 0.86 ALDH1A1 (0.55) MAPTPKMRAB9ALMNAMEN1
SCHEMBL14727179 0.86 ALDH1A1 (0.55) MAPTPKMRAB9ALMNAMEN1
SCHEMBL217123 0.86 ALDH1A1 (0.55) MAPTPKMRAB9ALMNAMEN1
SCHEMBL7853742 0.85 PKM (0.60) MAPTPKMLMNAMEN1KMT2A
SCHEMBL17933392 0.85 PKM (0.60) MAPTPKMLMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3728234-B1 RADIOLABELED COMPOUNDS HOFFMANN LA ROCHE (CH) 2025-05-14 EP disclosed
US-11541132-B2 Radiolabeled compounds HOFFMANN-LA ROCHE INC. (US) 2023-01-03 US disclosed
EP-3728234-A1 RADIOLABELED COMPOUNDS F. Hoffmann-La Roche AG (CH) 2020-10-28 EP disclosed
US-20200316232-A1 RADIOLABELED COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2020-10-08 US disclosed
CN-111511732-A Radiolabelled compounds 豪夫迈·罗氏有限公司 2020-08-07 CN disclosed
US-9057018-B2 Polymerizable liquid crystal compound, polymerizable liquid crystal composition, and polymer thereof JNC CORPORATION (JP) 2015-06-16 US disclosed
US-8623476-B2 Polarizing element and method of producing the same FUJIFILM CORPORATION (JP) 2014-01-07 US disclosed
US-20130169896-A1 STEREO IMAGE PRINT AND METHOD OF PRODUCING THE SAME FUJIFILM CORPORATION (JP) 2013-07-04 US disclosed
US-8477423-B2 Method of producing a patterned birefringent product FUJIFILM CORPORATION (JP) 2013-07-02 US disclosed
US-8477275-B2 Optical film and liquid crystal display device FUJIFILM CORPORATION (JP) 2013-07-02 US disclosed
WO-1991009848-A1 PYRIDINONES USEFUL AS ANTIATHEROSCLEROTIC AGENTS THE UPJOHN COMPANY (US) 1991-07-11 WO disclosed
US-4593119-A ADRENERGIC BLOCKING AGENTS OF SHORT DURARION AMERICAN HOSPITAL SUPPLY CORPORATION (US) 1986-06-03 US disclosed
US-4387103-A SHORT ACTING BETA BLOCKING AGENTS AMERICAN HOSPITAL SUPPLY CORPORATION (US) 1983-06-07 US disclosed
EP-0065542-A4 COMPOUNDS SUITABLE FOR TREATMENT OR PROPHYLAXIS OF CARDIAC DISORDERS. AMERICAN HOSPITAL SUPPLY CORP (US) 1983-04-25 EP disclosed
EP-0065542-A1 COMPOUNDS SUITABLE FOR TREATMENT OR PROPHYLAXIS OF CARDIAC DISORDERS. AMERICAN HOSPITAL SUPPLY CORP (US) 1982-12-01 EP disclosed
WO-1982001869-A1 METHOD FOR TREATMENT OR PROPHYLAXIS OF CARDIAC DISORDERS AMERICAN HOSPITAL SUPPLY CORP (US) 1982-06-10 WO disclosed
EP-0053435-A1 Compounds suitable for treatment or prophylaxis of cardiac disorders AMERICAN HOSPITAL SUPPLY CORPORATION (US) 1982-06-09 EP disclosed
US-4070415-A Thermoplastic molding compositions on the basis of polyoxymethylenes HOECHST AKTIENGESELLSCHAFT (DT) 1978-01-24 US disclosed
US-3980734-A Thermoplastic moulding compositions based on poly (oxymethylene) HOECHST AKTIENGESELLSCHAFT (DT) 1976-09-14 US disclosed
US-3961071-A CARDIOVASCULAR DISORDERS, 1-PHENOXY-2-HYDROXY-3-TERT-BUTYLAMINO PROPANES BOEHRINGER INGELHEIM GMBH (DT) 1976-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11541132-B2 Radiolabeled compounds SNCA, APP, BACE1 MAPT 16/4885PKM 3491/4885RAB9A 163/4885
US-20200316232-A1 RADIOLABELED COMPOUNDS SNCA, APP, BACE1 MAPT 17/4885PKM 3636/4885RAB9A 160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.